Using a multi-tiered, case-control association design, scanning 25 215 gene-centric SNPs, we previously identified two psoriasis susceptibility genes: IL12B and IL23R. These results have recently been confirmed. To better characterize the IL23R psoriasis-association, we used a fine mapping strategy to identify 59 additional IL23R-linked SNPs, which were genotyped in our three independent, white North American sample sets (42800 individuals in toto). A sliding window of haplotype association demonstrates colocalization of psoriasis susceptibility effects within the boundaries of IL23R across all sample sets, thereby decreasing the likelihood that neighboring genes, particularly IL12RB2, are driving the association at this region. Additional haplotype work identified two 5-SNP haplotypes with strong protective effects, consistent across our three sample sets (OR common ¼ 0.67; P comb ¼ 4.32E-07). Importantly, heterogeneity of effect was extremely low between sample sets for these haplotypes (P Het ¼ 0.961). Together, these protective haplotypes attain a frequency of 16% in controls, declining to 11% in cases. The characterization of association patterns within IL23R to specific predisposing/protective variants will play an important role in the elucidation of psoriasis etiology and other related phenotypes. Further, this work is essential to lay the foundation for the role of IL23R genetics in response to pharmaceutical therapy and dosage.
Introduction
Worldwide, psoriasis is the most common systemic autoinflammatory disorder affecting 0.5-3% of the general population. The disease is typified by overproliferation of keratinocytes and recruitment of immunocompetent cells, including CD4 þ T lymphocytes, to the dermal tissues generating chronic inflammation. 1 Affecting joints and surrounding tissues in 10-30% of psoriatic patients, inflammatory arthritis markedly impacts mobility and can cause irreversible joint destruction. Several genetic and epidemiological studies have demonstrated that Crohn's disease, cardiovascular disease and possibly metabolic syndrome are comorbid with psoriasis, particularly with more severe, earlier onset psoriasis. 2, 3 Griffiths and Barker 4 provide a current review of psoriasis etiology and clinical features.
Although great strides have been made advancing the understanding of psoriasis etiology and pathogenesis, it is clear that much remains to be elucidated. It is well understood that psoriasis has a strong genetic component. Several family-based studies have shown marked increases in psoriasis risk as relatedness increases; most notably psoriasis risk rises from 20% in dizygotic twins to 70% in monozygotic twins. 5 For decades both association and linkage results have pointed to a strong predisposing effect from the MHC region, and recent association-based evidence has highlighted HLA-Cw*0602 as a likely primary candidate responsible for this effect. 6 Broadly speaking, the smaller susceptibility effects of non-MHC loci have taken longer to identify at high resolution. Following genome-wide linkage studies, evidence for psoriasis-associated variants segregating at 17q25 has been intriguing, albeit inconsistent in location and signal strength. [7] [8] [9] Recently, we have reported psoriasis-associated diplotypes at IL12B, confirming and extending the previous work by Tsunemi et al., 10 and predisposing/protective diplotypes at IL23R using a multi-staged, case-control design, scanning 25 215 genecentric single nucleotide polymorphisms (SNPs). 11 These results have been verified in four independent studies [12] [13] [14] [15] and have paralleled association studies in related diseases. One of the IL23R missense SNPs implicated in psoriasis, R381Q, has also been strongly associated with several autoinflammatory phenotypes: several studies have found R381Q-mediated predisposition to adult inflammatory bowel disease (IBD), especially Crohn's disease [16] [17] [18] [19] [20] [21] and pediatric Crohn's disease in individuals of European descent, [22] [23] [24] two sizable studies reported association of multiple IL23R SNPs with ankylosing spondylitis (AS) 25, 26 and a North American study demonstrated IL23R susceptibility for Graves' ophthalmopathy (GO). 27 IL23R polymorphisms have also been studied in celiac disease with mildly significant results 28 and multiple sclerosis with conflicting results. 25, [28] [29] [30] [31] In addition, Zhang et al. 32 have recently reported a strong non-MHC psoriasis-association with haplotypes at IL15 in Han Chinese and we have published suggestive findings implicating IL13 and/or other variants in the 5q31 cytokine-rich region. 33 In this study, we focused on the IL23R region and extended our initial genetic analysis by fine mapping the association signal over 336 kb in our three case-control sample sets. Haplotype, association decay with linkage disequilibrium and conditional association analyses were performed to shed light on the psoriasis genetics in this region of chromosome 1p31.3.
Results
Genotyping for this study was performed on three independent sample sets consisting of white North American psoriasis cases and controls, totaling 1444 cases and 1382 controls. Basic demographic and clinical characteristics of these sample sets are described in a previous publication. 2 A type of genomic-control analysis was performed on pooled genotype data from the initial sample set which effectively ruled out large population stratification effects. 2 Applying our fine mapping SNP selection algorithm (described in the Materials and methods section), we identified 59 additional SNPs for interrogation in our three sample sets, for a total of 61 SNPs covering 338 kb (rs7530511, P310L; and rs11209026, R381Q were previously genotyped in all three sample sets). Thirty-one of these fine-mapping SNPs were within the coding region or the 3 0 UTR of IL23R. Figure 1a shows a positional plot of the selected SNPs with the location of the genes in this region of chromosome 1p31.3, with a more detailed view presented in Figure 1b focusing on individual SNPs genotyped within IL23R.
Of the 61 SNPs evaluated, eight had Mantel-Haenszel continuity-corrected P-values (MH P-values combine association evidence across the three sample sets, accounting for direction of effect) below 0.05. Supplementary Table S1 shows these results as well as allele frequencies, genotypic 2 d.f. P-values and P-values for the exact test of Hardy-Weinberg equilibrium for each sample set. Mantel-Haenszel allelic odds ratio and 95% confidence intervals are also presented (these were calculated jointly across the three sample sets). Six of these eight significant SNPs reside within the IL23R coding region and the remaining two are located in the intergenic region between IL23R and IL12RB2. These eight SNPs include the original two missense SNPs previously reported, rs7530511 (P310L) and rs11209026 (R381Q).
Prior to tests of haplotype association, two types of graphical representations of linkage disequilibrium (LD) patterns were constructed: To characterize the pairwise correlation structure for the entire 338 kb region, we generated a heatmap for cases and controls combined using the r 2 and D 0 statistics (Figure 2a ). Individual pairwise LD values with corresponding SNPs are given in Supplementary Table S2 . All three sample sets were combined for this analysis. The r 2 heatmap shows an absence of solid block patterns. Rather, there are two very roughly-defined block structures in the region with slightly higher average r 2 values than the surrounding regions. These weak blocks are highly peppered with pairwise comparisons of low LD. More pronounced LD structure is displayed in the D 0 heatmap, with two or three blocks covering the region. Given the fine mapping SNP selection procedure employed where SNPs were genotyped if they exhibited high LD (as measured by r 2 ) with one of the originally associated missense SNPs (P310L or R381Q) and other SNPs were tagging SNPs reducing redundancy, we would not expect to observe strong block structures. From our r 2 data, the first weak block extends roughly from intron 3 of C1orf141 into the 5 0 region of IL12RB2 and the second weak block covers part of the first intron of IL12RB2 through 28 kb 5 0 of SERBP1. As much of the association signal was driven by rs11209026 (R381Q) and other studies have identified this missense polymorphism as being strongly associated with the related phenotypes studied, we plotted the Mantel-Haenzsel P-value (combining the three sample sets) as a function of r 2 with R381Q ( Figure 2b ). Under a model where R381Q is solely and causally responsible for the association patterns observed, we expect the approximate relationship: log P M Er 2 log P D ; where P M is the association P-value at a marker in linkage disequilibrium with the causative site, P D is the association P-value at the causative site, in this case R381Q, r 2 is the pairwise LD measure between the two sites and equal numbers of genotypes are assayed at each site. This association decay analysis suggests that some SNPs in low LD with R381Q may independently contribute to disease status as they substantially depart from the expected relationship.
In our previous publication we constructed haplotypes for P310L and R381Q as haplotype association tests can be more informative than a single marker test under many models where cis-effects play an important role. 34 Even though these SNPs were not in high LD, the number of double heterozygotes was small and hence linkage phase is unambiguous in the large majority of individuals. With these two missense polymorphisms, carrying the proline-arginine polypeptide-encoding gene shows susceptible effects whereas both the leucine-arginine and proline-glutamine polypeptides confer protective effects. For this study, we used the fine mapping data to scan this region positionally for haplotype effects using a sliding window approach. A window size of three adjacent SNPs was used. We present a positional plot of the global haplotype P-value for each window ( Figure 3) . The plot shows an analysis combined across sample sets using the Fisher's combined P-value method. The results indicate rather narrow peaks of association centering on IL23R intron 8 through intron 9 and including the R381Q polymorphism in exon 9-a span of 12 kb. Four SNPs generated this association signal: rs10789229, rs10889671, rs11209026 (R381Q) and rs10889674; with the first window (rs10789229-rs10889671-rs11209026) producing a combined global P-value (2-tailed in each sample set) of 1.28E-04 and the second window (rs10889671-rs11209026-rs10889674) yielding a combined global P-value (also 2-tailed in each sample set) of 6.42E-05. Although these haplotype association windows were less significant in comparison with rs11209026, further work (elaborated below) is required to determine if rs11209026 is the sole driver of this association peak because of differences in d.f. and whether or not narrow hypotheses are tested. Through the association and LD analyses, it The combined P-value from the continuity-corrected MantelHaenzsel test for all individual SNPs is plotted as a function of linkage disequilibrium with R381Q, as measured by the r 2 statistic. Under the model where R381Q is solely responsible for association patterns at IL23R, we expect an approximate logarithmic relationship as shown by the diagonal line. Those SNPs that may exhibit psoriasis effects independent of R381Q are circled.
IL23R
IL12RB2 SERBP1 C1orf141 Figure 3 Haplotype sliding window. A sliding window of haplotype association was performed. Estimated haplotypes using an EM algorithm and subsequent analyses were obtained from Haplo.Stats. A 3-SNP window was used. Global P-value for each window is plotted against the average position of the three SNPs in that window. Gene boundaries are displayed.
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VE Garcia et al was apparent that although these four IL23R SNPs generated the peak association signal, additional psoriasis-association effects may be possible through haplotypes derived from additional SNPs (for example, P310L). Analysis of pairwise LD and association results indicate that within the eight SNPs having significant Mantel-Haenszel P-values, rs7530511 is highly correlated with rs10889671 (intron 8, IL23R SNP; r 2 ¼ 0.943); and similarly, rs11209026 is highly correlated with rs11465804 (intron 8, IL23R SNP; r 2 ¼ 0.852). We then proceeded to interrogate these data with several subsequent haplotype analyses.
We commenced another haplotype-based investigation by using the five SNPs that exhibited the strongest and most consistent single-SNP association signals: rs7530511, rs11465804, rs10889671, rs11209026 and rs1857292. These SNPs span 53 kb from exon 7 in IL23R to the intergenic region between IL23R and IL12RB2. The five-SNP haplotypes were estimated and tested for association in the three sample sets. Five primary haplotypes were found (above 1% frequency), two of which conferred significant protection against psoriasis susceptibility (Table 1a) . Together, these two (completely divergent) protective haplotypes, TTAGT and CGGAA, were present on 16% of control chromosomes, decreasing to 11% in cases. The effect of these protective haplotypes was consistent across sample sets (OR SS1 ¼ 0.66, OR SS2 ¼ 0.67, OR SS3 ¼ 0.69), and the combined analysis was rather significant (P MH ¼ 4.32E-07). Importantly, the level of heterogeneity of effect was not significant across sample sets for the protective haplotype grouping of TTAGT and CGGAA versus all other haplotypes (P Het ¼ 0.961) as determined from the Mantel-Haenszel procedure to test odds ratios for homogeneity (see Materials and methods).
We then systematically evaluated all possible combinations of these five SNPs in an exploratory analysis to see if we could eliminate one or more of these SNPs and retain or increase the significance of the association result. Eliminating rs11465804 and rs1857292 from the haplotypes yielded a simpler, slightly stronger association result for the protective haplotypes (TAG and CGA versus others; P MH ¼ 3.88E-08) (Table 1b) , although it should be noted that the increase in significance may be because of stochastic effects given that many combinations of haplotypes were explored. Without these two SNPs, the frequencies of the resulting protective haplotypes increased to 20% in controls and 14% in cases.
Visual inspection of the LD, association and numerous haplotype results spawned a curiosity to better understand the physical extent of the protective haplotypes in this region. Hence, we expanded the haplotype analysis to include all contiguous markers such that the association signal was not substantially diminished by estimated historical recombination events. This region appeared to extend 55 kb from P310L through the 3 0 region of IL23R to rs11209032 in the IL23R-IL12RB2 intergenic region. Haplotype analysis was performed on all twenty-three markers in this region (Table 2a) . Again, two common protective haplotypes were identified. Although the initial five-and three-marker protective haplotypes described above did not share alleles at any sites, the two protective haplotypes from the twentythree marker analysis had twelve markers with the same alleles on both haplotypes. As no other common (41%) haplotypes shared the alleles at these 12 markers, we reduced the analysis to those 12 markers and ran another haplotype analysis (Table 2b) . Notably, the protective haplotype from this reduced set of SNPs, AGTTCCTCCCAG, carries substantial effects (frequency in cases ¼ 12%, frequency in controls ¼ 17%; OR MH ¼ 0.68; TTAGT and CGGAA haplotypes combined.
Detailed genetic characterization VE Garcia et al P MH ¼ 3.18E-07) and does not include P310L, R381Q or SNPs in high LD with these two missense SNPs (rs10889671, rs1857292, or rs11465804). In addition, this haplotype is remarkably similar in frequency and effect size across all three sample sets. This is not the case for the three marker haplotypes (rs7530511-rs10889671-rs11209026) described previously with the TAG haplotype exhibiting the strongest protective effects in the Utah population-derived sample set 1 whereas the CGA haplotype was stronger in the remaining two sample sets (derived from the North American white population in general). With this result, an immediate line of further inquiry is whether or not this 12-marker haplotype represents a variant contributing to psoriasis association independently of P310L and R381Q. To address this we dichotomized the 12-marker haplotypes into the protective haplotype described above and an aggregate of all other haplotypes, then we did the same for the rs7530511-rs11209026 haplotypes (TG and CA protective haplotypes combined together versus CG and TA combined together). A diplotype-based, squared correlation coefficient r 2 statistic was then calculated between the two haplotype groupings. All individuals were used across all sample sets for this calculation. The resulting value, r 2 ¼ 0.78, indicated a fairly high degree of correlation between the two diplotype groupings, thereby suggesting that although they were not completely redundant, these were not independent effects.
The LD patterns and haplotype results appear to indicate that more than one polymorphism is contributing to the psoriasis association linked to IL23R. To formally investigate this, we performed a test of conditional association on SNPs having the most significant combined P-values (Po0.005) for the 2 d.f. genotype test and exhibiting significant Mantel-Haenzsel confidence intervals (95% CI excluding 1.0) for the allelic OR jointly calculated over the three sample sets. As some of these SNPs clustered into 'LD groups' consisting of SNPs in very high LD and similar statistical significance for psoriasis association, a representative SNP was selected from each LD group when appropriate. Six SNPs met these criteria: the missense SNPs rs7520511 (P310L) and rs11209026 (R381Q), rs10889674 (putative transcription factor-binding site, intron 9 IL23R), rs1857292 (3 0 of IL23R), rs11465804 (intron 8 of IL23R) and rs10889671 (intron 8 IL23R). Rs11465804 and rs10889671 were excluded from this analysis because of high LD with one of the missense SNPs (rs10889671-rs7530511 r 2 ¼ 0.943; rs11465804-rs11209026 r 2 ¼ 0.852) and as both missense SNPs had slightly elevated significance when compared with these LD counterparts. The conditional association permutation test revealed that the genotype association at R381Q remained significant after fixing the genotypes at P310L (P comb ¼ 0.00031), or either of the remaining two SNPs (P comb ¼ 0.0183, fixing genotypes at rs10889674; P comb ¼ 0.0027, fixing genotypes at rs1857292). Conversely, the genotype association at P310L was also significant, albeit mildly so, following conditioning on R381Q genotypes (P comb ¼ 0.0299); however, the moderate LD between P310L and the other two SNPs removed the association at P310L. These results for the mutual conditionally independent association of the two missense SNPs were not unexpected given the very low amount of LD between these two SNPs. Hence, there is some evidence of at least two IL23R-linked polymorphisms independently contributing to psoriasis.
As other SNPs, not genotyped in this study could possibly drive the association results observed here, we investigated the HapMap LD results for the CEU samples between genomic positions 67,225,114-67,725,113 on Build 36. 35 Examining four key SNPs from this study, rs7530511, rs10889671, rs11465804 and rs11209026, we found that seven SNPs were in substantial LD (r 2 40.50) with either rs7530511, rs10889671 or both: rs2863212 (IL23R intron 6), rs7528924 (IL23R intron 7), rs4655692 (IL23R intron 7), rs4655693 (IL23R intron 7), rs11804284 (IL23R intron 7), rs4655530 (IL23R intron 8) and rs2863209 (intragenic, within 8 kb 3 0 of IL23R). The remaining two SNPs were only in substantial LD with each other (r 2 rs11465804Àrs11209026 ¼ 0.852).
Discussion
We recently reported the finding that alleles at two missense SNPs segregating at IL23R were significantly associated with psoriasis. These results were replicated across our three sample sets and in external studies. Following up on our previous P310L-R381Q haplotype findings, fine mapping of the IL23R-linked region shows variants segregating at IL23R coding and flanking regions significantly associated with psoriasis. In particular, there are extended haplotypes in this region that protect against psoriasis susceptibility. Importantly, it Detailed genetic characterization VE Garcia et al also appears that at least two IL23R polymorphisms, P310L and R381Q, independently contribute to linkage disequilibrium with the psoriasis phenotype. In addition, both sliding window haplotype analyses and longer range haplotype work pinpointed the association signal to the IL23R coding region. This is particularly important as the interleukin 12 receptor subunit-encoding gene, IL12RB2, is located 47 kb from the 3 0 end of IL23R and some SNP pairs exhibit substantial and even perfect linkage disequilibrium between sites located in the coding regions of the two genes (as determined by genotyping in the CEU HapMap samples). Recent animal studies show that the IL12RB2 knockout mouse develops an autoimmune/lymphoproliferative disorder with aberrant IL-12 signaling. 36 Hence, IL12RB2 is a reasonable psoriasis candidate gene. However, the genetic results presented here seriously diminish the possibility that IL12RB2 alleles are primarily responsible for the psoriasis predisposing effects that we have observed.
The HapMap project has general population genotype data on both missense SNPs, rs7530511 (P310L) and rs11209026 (R381Q). 35 At rs11209026, the A allele (minor allele) was found on CEU and YRI chromosomes (8 out of 120 CEU chromosomes and 2 out of 120 YRI chromosomes), but not on chromosomes from the two East Asian samples (CHB and JPT). Hence, it is possible that rs11209026 may predispose some African and/or African-derived populations to autoimmunity and autoinflammatory traits, particularly if the effect size is larger in those subpopulations than European-derived samples. The rs7530511 SNP is polymorphic in all four HapMap sample sets, with varying frequencies: 15/120 CEU chromosomes, 2/90 CHB chromosomes, 3/88 JPT chromosomes and 35/118 YRI chromosomes; thereby suggesting that the autoinflammatory effects ascribed to P310L for our North American white samples might translate to these other populations. For each of these SNPs, the minor allele in humans appears to be derived as many vertebrates including the chimpanzee, macaque, mouse, rat, cow, dog and chicken carry the major allele nucleotides at the orthologous sites.
Importantly, these genetic findings coupled with results from multiple areas of research ranging from molecular immunology to clinical biology implicate the IL-23/T H -17 pathway as being central to chronic inflammatory conditions such as psoriasis and inflammatory bowel disease; the perturbation of which may disrupt the communication between the innate and adaptive immune responses. In sum, these studies demonstrate several key aspects of IL-23/T H -17 pathobiology related to psoriasis: (1) Both IL-12p40 and IL-23p19 mRNA expression levels are significantly elevated in both nonlesional psoriatic skin versus normal skin as well as lesional psoriatic skin versus non-lesional psoriatic skin. 37 43 and (5) clinical studies have shown dramatic efficacy of IL-12p40 antibodies in reducing symptoms in a high percentage of psoriatic subjects 44, 45 and those with active Crohn's disease. 46 These diverse studies have conspired to highlight the central function of the IL-23/T H -17 axis in mediating chronic inflammatory disease pathogenesis, downplaying the role of IL-12. Hence, full genetic description of both IL12B and IL23R, genes encoding for critical proteins in the IL-23/T H -17 response, is necessary to delineate specific variants predisposing and protective of disease and to further our understanding of the molecular pathobiology of autoinflammatory phenotypes.
Along with psoriasis, IL23R appears to play an important role in predisposition to other autoinflammatory Haplotypes built on: rs7530511, rs10489629, rs4655692, rs2201841, rs11465804, rs10489628, rs1343152, rs10789229, rs10889671, rs11209026, rs10889674, rs12085634, rs1343151, rs1008193, rs6693831, rs10889675, rs11465827, rs10889677, rs4655531, rs11209030, rs1857292, rs11209031 and rs11209032. Detailed genetic characterization VE Garcia et al diseases including IBD (particularly adult and pediatric Crohn's disease), [16] [17] [18] [19] [20] [21] [22] [23] [24] AS, 25, 26 and GO. 27 It is possible that IL23R variants also underlie susceptibility to celiac disease, 28 Graves' disease without ophthalmopathy 27 and multiple sclerosis, 28, 29 although the evidence is not currently strong for celiac disease and Graves' disease without opthalmopathy and is contradictory for multiple sclerosis. 25, 30, 31 Interestingly, multiple independent IL23R polymorphisms have been reported to be associated with AS, GO and Crohn's disease, suggesting a model of allelic heterogeneity within each disease where disruption of IL-23R function can occur from several distinct genetic insults. With AS, both R381Q and rs1343151 are replicated SNPs (only the former was associated with psoriasis in our study). Graves' disease offers a different view-unlike AS, Celiac disease, IBD and psoriasis, R381Q is not associated with Graves' disease or GO. Rather, two IL23R SNPs, which are not psoriasisassociated, rs2201841 and rs10889677, are associated with GO; whereas P310L may be associated with Graves' disease. Although R381Q seems to be the major IL23R susceptibility polymorphism for Crohn's disease with the minor allele conferring protective effects as in psoriasis, other independent SNPs such as rs7517847 play a role in Crohn's but not psoriasis predisposition.
Conversely, P310L appears to be significantly correlated with psoriasis, but not IBD. Understanding the complex, pleiotropic action of IL-23R and the specific variants that give rise to each of these autoimmune traits will undoubtedly increase progress in our understanding of the molecular pathophysiology underlying these chronic autoinflammatory conditions. Moreover, coupled with the recent advances in autoinflammatory biology, the IL23R variants described herein may lead to a deeper understanding of molecular action of targeted therapeutics such as the efficacious IL-12/IL-23 monoclonal antibodies [44] [45] [46] and prove useful in autoinflammatory pharmacogenetics.
Materials and methods

Subjects
The subjects in all the three sample sets were white North American individuals. Sample set 1 consisted of 467 psoriasis cases and 500 controls, all residing in either Utah or southern Idaho. Sample set 2 was obtained by the Genomics Collaborative Division of SeraCare Life Sciences and included 498 cases and 498 controls. Lastly, BioCollections Worldwide and Genomics Collaborative Division of SeraCare Life Sciences provided sample set 3, composed of 481 cases and 424 controls. Details concerning these subjects were previously described.
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All individuals included in this study were 18 years or older at the time of enrollment. All protocols were approved by national and/or local institutional review boards, and informed written consent was obtained from all subjects.
Genotyping
Individual genotyping was performed using allelespecific kinetic PCR on 0.3 ng of DNA and the resulting data hand-curated prior to statistical analyses without knowledge of case-control status. Our genotyping accuracy is consistently better than 99%.
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SNP Selection
We undertook a multifaceted approach to identify SNPs to genotype individually in a fine-scale mapping effort in the IL23R region. A 336 kbp region was selected across a 35 Next, we ran the tagging SNP program Redigo 47 on those SNPs in weak LD, selecting SNPs with the highest power to detect an arbitrary disease predisposing site in the region. Redigo uses a genotype-based approach that maximizes power to detect disease susceptibility SNPs. We then took all of the SNPs in the moderate-to-high LD group and reduced the set so that SNPs in extremely high LD (r 2 40.97) were represented by a single SNP. Lastly, any SNP with putative functional annotation was selected to be genotyped. In all, 61 SNPs, inclusive of the two SNPs fully genotyped in the original study, were identified and judged as being sufficient to cover both genetic models for the IL23R region.
Statistical analysis
Several analyses were performed on individual SNPs. We used an in-house genetic analysis application to analyze much of the data. Hardy-Weinberg equilibrium testing was accomplished through the exact test of Weir.
48 A William's-corrected G-test was used to calculate P-values for genotypic association. 49 Approximate confidence intervals for the odds ratios were calculated using the typical estimate of the s.e. of the log odds ratio. The Mantel-Haenszel procedure to test odds ratios for homogeneity (test of heterogeneity of effect) was performed following Sokal and Rohlf (Chapter 17, Reference 49 ). P-values were combined across sample sets using either the continuity-corrected Mantel-Haenszel statistic (eqn 17.22, reference 49 ) or the Fisher's combined P-value (omnibus procedure). 50 Similarly, Mantel-Haenszel common odds ratios were calculated to combine data across sample sets. 51 A Monte Carlo simulation was written in XLISP-STAT to calculate 95% confidence intervals on the common odds ratios. Typically, 20 000 iterations of the Monte Carlo were performed unless results were not sufficiently converging, in which case 40 000 iterations were used.
Pairwise linkage disequilibrium was calculated using either the LDMax package where 2-SNP haplotypes were estimated through an EM algorithm and the standard r 2 statistic employed, 52, 53 or, in some instances, we calculated an r 2 statistic using unphased genotype or diplotype data. Given perfect phasing for the double heterozygotes and Hardy-Weinberg equilibrium, these two methods yield identical values.
Sliding window haplotype association tests were performed by running Haplo.Stats 54 sequentially on adjacent sets of three SNPs. Plots of the global P-values from each window were plotted against the average position of the SNPs in the window. Additional haplotype and diplotype work was performed using the Pseudo-Gibbs sampling algorithm from the SNP Analyzer program 55 to estimate phase, followed by a William's-corrected G-test of homogeneity.
Similar to the haplotype method, 56 a test of pairwise conditional independence (that is, fixing the genotypes at one SNP and testing for the association at a second SNP) was performed through a permutation routine where case-control status is permuted against genotype data to generate a null distribution. For conditional independence hypotheses concerning only a small number of highly significant SNPs driving correlated SNPs to association solely through LD (such as is the case here), a permutation method has advantages over logistic regression models in that the P-values, given a sufficient number of iterations, will be appropriate regardless of LD levels, effect size and counts. Alternatively, we prefer logistic regression-based methods in situations that warrant inclusion of many SNPs and/or covariates with low to moderate LD/correlation levels and/or the hypothesis tested requires an adjustment to be performed on more than one SNP. Typically, 2000 iterations of the permutation were performed and P-values were calculated through a modeling procedure where a loglikelihood ratio test statistic is calculated for each of the permuted iterations. Next, the parameters of a g probability density are estimated from the permuted log-likelihood ratio test statistics and a P-value is calculated by integrating this null density from the observed log-likelihood ratio statistic. For a given number of permutation iterations, this modeling procedure gives more accurate P-values than simply taking the frequency of those permuted iterations that exceed the observed value.
